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Introduction. Increasingly, medical services must be more aware of the cost of our procedures to ensure adequate resource
optimization.
Objective. Based on the estimation of the relative value units, we intended to calculate the savings resulting from the implemen-
tation of hypofractionation in breast cancer.
Matherials and methods. As reported in literature, a relative unit value (RUV) corresponds to the equivalent value in time and cost
of human and technical resources, corresponding to a single session of 180–200 cGy. A medical visit is equivalent to 1.5 RUVs.
As there is no uniform system in Spain for calculating the levels of complexity in procedures, we have relied on the published
by the Andalusian Health Service, just to illustrate the comparison between hypofractionated and conventional treatment. In
2011 we treated in our department 153 breast cancers (107 patients – 69.9% – received 40.05Gy in 15 fractions and 46 patients –
30.1% – were treated in a conventional way). It represented the 19% of the clinical activity. We calculated the RUVs corresponding
to each treatment modality and compared the results. After that, we extrapolated the results to our department mixing both
treatments, and calculating the actual percentage savings.
Results. We have found that the total RUVs per patient in a hypofractionated treatment are 36.5 RVUs, while the corresponding
value in a conventional treatment is 49.5 RUVs (including simulation, clinical evaluations during treatment and evaluation of the
dosimetry). We treated 107 patients in a hypofractionated way (3905.5 RUVs) and performed 46 conventional treatments (2277
RUVs). Total RUVs: 6182.5. If all the patients of our department were treated conventionally, we would come to 7573.5 RUVs.
Therefore, we have achieved a saving of 18.37%.
Conclusion. Hypofractionation in patients in clinical indication represented a signiﬁcant saving in our department.
http://dx.doi.org/10.1016/j.rpor.2013.03.356
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Objectives. In March 2012 the Hospital Rey Juan Carlos activity began. At that time, we met the challenge of developing the
entire radiotherapy process in a paperless environment. The objective of this study is to present how we have implemented the
workﬂow and management in our Department of Radiation Oncology over the MOSAIQ network.
Materials and methods. In MOSAIQ network version 2.30 there is a personal space for each user where information of pending tasks
as well as the patient’s medical history with all administrative data, clinical monitoring during treatment, assessments of side
effects and all documents related to the simulation, planning, treatment veriﬁcation, record and report dosimetric treatment are
available. All these documents are legally validated by electronic signatures. We deﬁned user proﬁles, with three security levels
that allow you to view, modify or approve the different activities. All this information is collected in a database from which we
can obtain any kind of reports or statistics, essential for the management of the Service.
Results and discussion. Lists of Quality Assurance (QA) have been used to develop the workﬂow of our department. QA lists consist
of a series of successive activities, each one of them assigned to a responsible, which must be performed in a period of time. Each
user knows daily what work has to be done and in what timeframe. All legal requirements for planning approval, weekly reviews
of the processed data, dosimetric reports and daily treatment sheet have been agreed with the legal department of our hospital
giving legal validity to the usernames and passwords. In addition, it has been developed a roadmap in Radiation Oncology for
the patients, which is given to them on the starting day of the treatment and which reﬂects the appointment calendar on the
accelerator, the regular consultation with doctors and nurses and the scheduled analytical controls. We have also developed
templates to register the evaluation of the pathologies including weekly vital signs, laboratory data and side effects (CTC-AE
version 4) during treatment.
Conclusions. MOSAIQ network contains a number of very powerful and versatile tools for conﬁguring the workﬂow and manage-
ment tailored to the needs and working methods of each Radiation Oncology Department.
http://dx.doi.org/10.1016/j.rpor.2013.03.357
